Mechanistically, obesity-related mediators reinforce KRAS activation266 and stimulate downstream pathways, including the ERK pathway.34 DIO also increased the protein levels of YAP and TAZ in the pancreas of KC mice, which were decreased by the administration of metformin. Here, KRAS is linked to obesity due to melanocortin 4 receptor deficiency.